vertis Biotechnologie AG: Innovative services for a globally connected region

DSCF0757-Kopie

vertis Biotechnologie AG, founded as a spin-off of TU München-Weihenstephan uni­­­versity, is a research-focused organization active in the area of functional genome analysis. vertis is one of the lead­­ing companies in the fields of genome-wide RNA sequencing and extensive de-novo transcript profiling. Through years of basic research, vertis has developed in­­­no­­­vative tools for cloning and analyzing co­­d­ing (mRNA) and non-coding RNA from a wide range of organisms and starting ma­­­­­te­­rials, combining highest quality re­­sults with efficiency and cost effectiveness.
vertis – a partner in biotechnological and pharmaceutical research.

Vorlage_Logos

 

  1. Address

    Lise-Meitner-Straße 30
    D-85354 Freising
    Telefon +49 (0) 8161 14112-11
    Telefax +49 (0) 8161 14112-12
    info@vertis-biotech.com
    www.vertis-biotech.com

  2. Year of foundation

    2000
  3. Business activity

    5
  4. Executive Board

    Dr. Fritz Thümmler 


  5. Business activity

    • Ultra-tiefe RNA-Sequenzierung von
    kodierenden (mRNA, Transkriptom) und nicht-kodierende RNAs (z.B. MikroRNA) aus Eukaryonten und aus Prokaryonten
    • De-novo-Erstellung von genomweiten Expressionsprofilen aus MPSS-Daten
    • Herstellung von qualitativ hochwertigen cDNA-Banken in einer Vielzahl von
    unterschiedlichen Klonierungsvektoren